Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Cytosolic transport of citrate protects pancreatic cancer from ferroptosis under nutrient stress.

ABSTRACT: Pancreatic cancer is a deadly disease as the long-term overall survival rate is only 12%, indicating that there is no effective therapeutic approach available to the patients. Recent studies link the conditions in the pancreatic tumor microenvironment to the aggressive phenotype of the disease and drug resistance. The pancreatic tumor microenvironment is poorly perfused, which limits the nutrients and oxygen availability for tumor cells. We and others have demonstrated that cancer cells rewire their metabolism to adapt to harsh conditions present in the tumor microenvironment of pancreatic cancer. A better understanding of metabolic dependencies may assist in developing targeted therapies. Our results demonstrate that cytosolic transport of citrate via a transporter, SLC25A1, confers a survival advantage to pancreatic cancer cells by protecting them against ferroptosis, an iron-dependent cell death mechanism, under nutrient withdrawal. Additionally, targeting the transporter via a small molecule inhibitor of SLC25A1 prevents the growth of subcutaneous pancreatic xenograft tumors in animals. Any therapeutic advance in the area of pancreatic cancer beyond conventional chemotherapy would significantly improve lives and outcomes.

ORGANISM(S): Homo sapiens

PROVIDER: GSE286514 | GEO | 2026/01/12

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Impact of mitochondrial citrate carrier expression on metabolism in the developing heart

Project description:Slc25a1 encodes for the mitochondrial citrate carrier, a mitochondrial inner membrane transporter that mediates mitochondrial citrate export. Systemic deletion of Slc25a1 (both homozygous and heterozygous loss) leads to cardiac structural defects and mitochondrial dysfunction. Transcriptomic profiles of metabolic gene expression in the the developing mouse heart at E17.5 reveal alterations in metabolic pathways including oxdiative phosphorylation, supporting mitochondrial structural and functional defects observed with loss of this transporter.

2024-10-11 | GSE279295 | GEO

Cancer cells are sensitive to wild-type IDH1 inhibition under nutrient limitation

Project description:Pancreatic cancer cells alter their metabolism to survive cancer-associated stress. For example, cancer cells must adapt to steep nutrient gradients that characterize the natural tumor microenvironment. In the absence of adaptive strategies, harsh metabolic conditions promote free radicals and impair energy production in tumor cells. Towards this end, wild-type isocitrate dehydrogenase 1 (IDH1) activity is a metabolic requirement for cancer cells living in a harsh metabolic milieu. The cytosolic enzyme interconverts isocitrate and α-ketoglutarate (αKG) and uses NADP(H) as a cofactor. We show that under low nutrient conditions, the enzymatic reaction favors oxidative decarboxylation to yield NADPH and αKG. Metabolic studies showed that the IDH1 products directly support an antioxidant defense and mitochondrial function in stressed cancer cells. Genetic IDH1 suppression reduced pancreatic cancer cells' growth in vitro under low nutrient conditions and in mouse models of pancreatic cancer. Thus, intrinsic tumor microenvironment conditions sensitized wild-type IDH1 to FDA-approved AG-120 (ivosidenib) and revealed the drug to be a potent single-agent therapeutic in cell culture and diverse in vivo cancer models. This work identified a potentially new repertoire of safe cancer therapies, including a clinically available compound, to treat multiple wild-type IDH1 cancers, including pancreatic cancer.

2021-11-01 | GSE161073 | GEO

Study on the Molecular Mechanism of Salidroside@T-exo Inducing Breast Cancer Immune Microenvironment Remodeling and Reversing Acquired Resistance to Immunotherapy by Regulating the PI3K/AKT/mTOR Signaling Pathway

Project description:To elucidate how Salidroside-loaded, oligopeptide-modified tumor exosomes (Salidroside@T-exo) rewire the PI3K/AKT/mTOR axis to remodel the immune microenvironment (IME) and reverse acquired PD-1 resistance in breast cancer

2025-11-03 | PXD070218 |

Cytosolic fraction of MCF7 cells, SLC22A18 KD

Project description:The SLC22A18 gene, which encodes an orphan transporter, is located at the 11p15.5 imprinted region, an important tumor-suppressor gene region. However, the role of SLC22A18 in tumor suppression remains unclear. Here, we investigated the involvement of SLC22A18 in cell growth, invasion and drug resistance of MCF7 human breast cancer cell line. Western blot analysis indicated that SLC22A18 is predominantly expressed at intracellular organelle membranes. Quantitative proteomics showed that knockdown of SLC22A18 significantly altered the expression of 578 (31.0%) out of 1867 proteins identified, including proteins related to malignancy and poor prognosis of breast cancer.

2019-06-01 | PXD010183 | JPOST Repository

Selective Dependence on Stromal Acetate induced Polyamine Metabolism Provides Unique Therapeutic Opportunities in Pancreatic Cancer

Project description:The ability of tumor cells to thrive in harsh microenvironments depends on the utilization of nutrients available in the milieu. However, the signaling and nutritional potential of the stromal cell-secreted metabolites remains poorly understood. We identified a novel metabolic crosstalk between cancer associated fibroblasts (CAFs) and pancreatic cancer cells. We demonstrate that pancreatic CAFs regulate tumor cell metabolism through the secretion of acetate, which can be blocked by silencing ACLY in CAFs. Cancer cells present a unique dependence on CAF-derived acetate under acidosis. We further show that ACSS2 channels the exogenous acetate to regulate the dynamic cancer epigenome and transcriptome, thereby facilitating cancer cell survival in the acidic microenvironment. Comparative H3K27ac ChIP-Seq and RNA-Seq analyses revealed alterations in polyamine homeostasis through regulation of SAT1 gene expression and enrichment of the SP1-responsive signature. We observed novel acetate/ACSS2-mediated acetylation of SP1 at lysine 19 residue that increased SP1 protein stability and transcriptional activity. Genetic or pharmacologic inhibition of the ACSS2-SP1-SAT1 axis diminished tumor burden in mouse models. Increased SAT1-mediated production of N1-acetylspermidine correlated with disease progression in the spontaneous tumor progression model and poor survival in cancer patients. These results reveal that the metabolic flexibility imparted by the stroma-derived acetate enabled cancer cell survival under acidosis via the ACSS2-SP1-SAT1 axis.

2023-10-20 | MSV000093165 | MassIVE

Super-paramagnetic iron oxide nanoparticles reprogram the tumor microenvironment and reduce lung cancer growth

Project description:Tumor associated macrophages (TAMs) are known to play a role in a multitude of processes that facilitate lung cancer growth, including the suppression of tumoricidal immune activation and the absorption of chemotherapeutics. Therefore, deciphering new therapies to reprogram TAMs towards an anti-tumor phenotype is at the cutting-edge of therapy development. The presence of iron-loaded macrophages has been associated with a better prognosis in lung cancer patients. Iron accumulation in macrophages stimulates pro-tumoricidal macrophage activity that triggers cytotoxic T-cell responses in the tumor microenvironment. In this study, we propose super-paramagnetic iron oxide nanoparticles (SPIONs) as a promising anti-lung cancer adjuvant therapy to reduce tumor cell growth. We used SPIONs to target iron to macrophages and observed that SPION-loaded macrophages reduced tumor cell growth due to the oxidative stress. Additionally, we found that SPIONs completely rewire the tumor microenvironment in mice towards an anti-tumor state and that in combination with crizotinib, a lung cancer targeted therapy, SPIONs show an additive effect in decelerating tumor growth

2024-04-18 | PXD040145 | Pride

Pancreatic tumor microenvironment confers highly malignant properties on pancreatic cancer cells

Project description:Pancreatic tumor microenvironment confers highly malignant properties on pancreatic cancer cells

| PRJNA422050 | ENA

Gene expression profile at single cell level of an orthotopic mouse model with ZEB1 knockdown in the KPC cell line and control group mouse [scRNA-seq]

Project description:Pancreatic cancer is characterized by high resistance to chemotherapy and immunotherapy and there are no effective drugs which leads to poor overall survival for pancreatic cancer patients. The transcription factor ZEB1 promotes cellular plasticity and tumor metastasis in pancreatic cancer. We employed single-cell RNA sequencing and spatial transcriptomic sequencing to analyze ZEB1-mediated remodeling of the tumor microenvironment in pancreatic cancer.

2025-08-20 | GSE281084 | GEO